These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 26501714)
1. Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis. Maret-Ouda J; Konings P; Lagergren J; Brusselaers N Ann Surg; 2016 Feb; 263(2):251-7. PubMed ID: 26501714 [TBL] [Abstract][Full Text] [Related]
2. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis. Kauttu TM; Rantanen TK; Sihvo EI; Räsänen JV; Puolakkainen P; Salo JA Eur J Cardiothorac Surg; 2011 Dec; 40(6):1450-4; discussion 1454. PubMed ID: 21546258 [TBL] [Abstract][Full Text] [Related]
3. Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries. Maret-Ouda J; Santoni G; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J Ann Surg; 2021 Dec; 274(6):e535-e540. PubMed ID: 31800492 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of surgical patients with gastroesophageal reflux disease and Barrett's esophagus]. Zsolt S; Paszt A; Géczi T; Abrahám S; Tóth I; Horváth Z; Pieler J; Tajti J; Varga A; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Lázár G Magy Seb; 2014 Oct; 67(5):287-96. PubMed ID: 25327403 [TBL] [Abstract][Full Text] [Related]
5. Does antireflux surgery prevent progression of Barrett's esophagus? Lord RV Minerva Chir; 2011 Feb; 66(1):1-6. PubMed ID: 21389920 [TBL] [Abstract][Full Text] [Related]
6. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204 [TBL] [Abstract][Full Text] [Related]
7. Antireflux Surgery and Barrett's Esophagus: Myth or Reality? Herbella FAM; Schlottmann F; Patti MG World J Surg; 2018 Jun; 42(6):1798-1802. PubMed ID: 29264726 [TBL] [Abstract][Full Text] [Related]
8. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited. Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425 [TBL] [Abstract][Full Text] [Related]
9. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)? Spechler SJ Dig Dis; 2014; 32(1-2):156-63. PubMed ID: 24603402 [TBL] [Abstract][Full Text] [Related]
10. Antireflux Surgery Versus Antireflux Medication and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus. Åkerström JH; Santoni G; von Euler Chelpin M; Ness-Jensen E; Kauppila JH; Holmberg D; Lagergren J Gastroenterology; 2024 Jan; 166(1):132-138.e3. PubMed ID: 37690771 [TBL] [Abstract][Full Text] [Related]
11. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. Maret-Ouda J; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J JAMA Oncol; 2018 Nov; 4(11):1576-1582. PubMed ID: 30422249 [TBL] [Abstract][Full Text] [Related]
12. Antireflux surgery for Barrett's oesophagus. Lord RV ANZ J Surg; 2003 Apr; 73(4):234-6. PubMed ID: 12662234 [TBL] [Abstract][Full Text] [Related]
13. Acid suppression and surgical therapy for Barrett's oesophagus. de Jonge PJ; Spaander MC; Bruno MJ; Kuipers EJ Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):139-50. PubMed ID: 25743462 [TBL] [Abstract][Full Text] [Related]
14. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Corey KE; Schmitz SM; Shaheen NJ Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338 [TBL] [Abstract][Full Text] [Related]
15. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms. Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964 [TBL] [Abstract][Full Text] [Related]
16. The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study. Markar SR; Arhi C; Leusink A; Vidal-Diez A; Karthikesalingam A; Darzi A; Lagergren J; Hanna GB Ann Surg; 2018 Nov; 268(5):861-867. PubMed ID: 30048317 [TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. Spechler SJ; Lee E; Ahnen D; Goyal RK; Hirano I; Ramirez F; Raufman JP; Sampliner R; Schnell T; Sontag S; Vlahcevic ZR; Young R; Williford W JAMA; 2001 May; 285(18):2331-8. PubMed ID: 11343480 [TBL] [Abstract][Full Text] [Related]
18. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma. Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for esophageal adenocarcinoma after antireflux surgery. Löfdahl HE; Lu Y; Lagergren P; Lagergren J Ann Surg; 2013 Apr; 257(4):579-82. PubMed ID: 23426349 [TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus in patients with gastroesophageal reflux disease. Medical therapy or antireflux surgery? Klaus A; Mühlmann G; Kirchmayr W; Weiss H; Wetscher GJ Minerva Chir; 2002 Aug; 57(4):397-402. PubMed ID: 12145570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]